Drug discovery opportunities from apoptosis research

Current Opinion in Biotechnology

Volumn 11, Issue 6, 2000, Pages 586-592

  Reed, John C ^a   Tomaselli, Kevin J ^b  

^a BURNHAM INSTITUTE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2;

APOPTOSIS; CELL DEATH; DRUG RESEARCH; ENZYME ACTIVE SITE; ENZYME MECHANISM; ENZYME REGULATION; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATOR GENE; REVIEW;

EID: 0033636355     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00148-8     Document Type: Review

References (60)

1. Apoptosis: An overview
2. Caspases: Enemies within
3. Proteases to die for
4. Caspases: Intracellular signaling by proteolysis
5. Caspases and cytokines: Roles in inflammation and autoimmunity
6. Apoptosis in the pathogenesis and treatment of disease
7. Caspase activation: The induced-proximity model
8. Tumor necrosis factor receptor and Fas signaling mechanisms
9. Transducing signals of life and death
10. Cytochrome C: Can't live with it; Can't live without it
11. Mitochondria and apoptosis
12. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenataly
13. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade
14. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
15. Differential requirement for caspase 9 in apoptotic pathways in vivo
16. The atomic-resolution structure of human caspase-8, a key activator of apoptosis
17. The three-dimensional structure of caspase-8: An inhibitor enzyme in apoptosis
18. 2 homodimer
19. Structure and mechanism of interleukin-1β converting enzyme
20. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis
21. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-asp-val-ala-asp fluoromethyl ketone
22. Prediction of the tertiary structure of a caspase-9/inhibitor complex
23. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock
24. Defects in regulation of apoptosis in caspase-2-deficient mice
25. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE
26. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
27. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
28. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic, a beta peptide formation
29. A combinatorial approach defines specificities of members of the caspase family and granzyme B
30. Conformationally constrained inhibitors of caspase-1 (interleukin-1 beta converting enzyme) and of the human CED-3 homologue caspase-3 (CPP32, apopain)
31. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis
32. Attentuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family
33. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo
34. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo
35. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines
36. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model
37. Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity
38. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
39. The CARD domain: A new apoptotic signalling motif
40. The NACHT family - A new group of predicted NTPases implicated in apoptosis and MHC Transcription activation
41. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis
42. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
43. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation
44. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kB
45. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB
46. Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-α and Fas-induced cell death
47. Mechanisms of apoptosis
48. The Bcl-2 protein family: Arbiters of cell survival
49. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease
50. Bcl-2-family proteins - The role of the BH3 domain in apoptosis
51. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis
52. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
53. IAP family proteins: Suppressors of apoptosis
54. An exegesis of IAPs: Salvation and surprises from BIR motifs
55. Insights into programmed cell death through structural biology
56. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating lAP inhibition
57. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing lAP proteins
58. Structural and biochemical basis of apoptotic activation by Smac/DIABLO
59. An emerging blueprint for apoptosis in Drosophila
60. A combinatorial approach for determining protease specificities: Application to interleukin-1beta converting enzyme (ICE)